Login to Your Account



NewCo News

Third Rock-Launched GBT Raises $40.7M in Series A

By Marie Powers
Staff Writer

Thursday, June 14, 2012
Global Blood Therapeutics Inc. (GBT) came charging out of the gate Thursday with a $40.7 million Series A, becoming the first company "organically constructed, formed and launched" from the West Coast office of Third Rock Ventures LLC, according to Mark A. Goldsmith, the company's CEO and a Third Rock venture partner.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription